Antimicrobial activity of B-lock against bacterial and Candida spp. causing catheter-related bloodstream infections

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 4430-4431

  Ghannoum, M A ^a,c   Isham, N ^a   Jacobs, M R ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Great Lakes Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; B LOCK; EDETIC ACID; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM; CANDIDA; CATHETER INFECTION; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; INTRAVASCULAR CATHETER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTERIA; CANDIDA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; DRUG COMBINATIONS; EDETIC ACID; ETHANOL; MICROBIAL SENSITIVITY TESTS; TRIMETHOPRIM;

EID: 80051827693     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00677-11     Document Type: Article

References (11)

1. Chandra, J., P K Mukherjee, K. Appelt, M. Lanzilotti, and M A Ghannoum. 2008. B-Lock containing Ca-EDTA exhibits wide-spectrum activity against multidrug resistant bacteria and fungi, abstr. M740, p. 637. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC)/Infect. Dis. Soc. Am. (IDSA) 46th Annu. Meet American Society for Microbiology and Infectious Diseases Society of America, Washington, DC.
2. Chandra, J., P K Mukherjee, and M A Ghannoum. 2007. Optimization of antibiofilm lock solution for activity against fungal and bacterial biofilms, abstr. M-1854, p. 460-461. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother.
3. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8th ed. Approved standard M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd ed. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Fried, V A, and A. Novick. 1973. Organic solvents as probes for the structure and function of the bacterial membrane: Effects of ethanol on the wild type and an ethanol-resistant mutant of Escherichia coli K-12. J. Bacteriol. 114:239-248.
6. Hu, K K, D L Veenstra, B A Lipsky, and S. Saint. 2004. Use of maximal sterile barriers during central venous catheter insertion: Clinical and economic outcomes. Clin. Infect. Dis. 36:1441-1445. (Pubitemid 39518206)
7. Maki, D G, D M Kluger, and C J Crnich. 2006. The risk of bloodstream infection in adults with different intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin. Proc. 81:1159-1171. (Pubitemid 44316281)
8. Marschall, J., et al. 2008. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl. 1):S22-S30.
9. Mermel, L A, et al. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infections: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
10. O'Grady, N P, et al. 2002. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recommend. Rep. 51:1-29.
11. Pittet, D., D. Tarara, and R P Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598-1601.